Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes

M. Morikawa, Y. Demura, D. Uesaka, T. Ishizaki, H. Itoh (Fukui, Japan)

Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques

Session: Diagnosis and staging of lung cancer: existing and new techniques
Session type: Oral Presentation
Number: 209

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Morikawa, Y. Demura, D. Uesaka, T. Ishizaki, H. Itoh (Fukui, Japan). Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes. Eur Respir J 2007; 30: Suppl. 51, 209

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Diagnostic imaging of lung cancer Source: Eur Respir J 2002; 19: 722-742 Year: 2002
Diagnostic imaging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=120 Year: 2001
Radiology of lung cancer Source: Eur Respir Mon; 2009: 44: 106–135 Year: 2009
Imaging can replace mediastinoscopy: CON Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
Imaging of cystic fibrosis: functional MRI versus conventional CT Source: Annual Congress 2007 - Imaging of inflammatory airway diseases Year: 2007
Imaging the pleura: CT scan, MRI and PET Source: ERS Skills Course 2016 Year: 2016
Endobronchial ultrasound and PET positive mediastinal lymph nodes Source: Annual Congress 2005 - Screening and imaging of lung cancer Year: 2005
The role of mediastinoscopy on staging of NSCLC patients with negative mediastinal lymph node uptake on positron emission tomography imaging Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 125s Year: 2006
Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography–computed tomography? Source: ERJ Open Res, 6 (4) 00103-2020; 10.1183/23120541.00103-2020 Year: 2020
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009
Small animal imaging using CT, PET and MRI Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development Year: 2013
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001
Advances in imaging Source: Eur Respir J 2001; 18: 867-871 Year: 2001
Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010
Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes Source: Eur Respir J 2006; 27: 276-281 Year: 2006
Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001
Computed tomography in staging for lung cancer Source: Eur Respir J 2002; 19: 40S-48S Year: 2002